Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964–2003 followed up to the end of 2006

Figures & data

Figure 1. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5-year relative survival for oesophageal cancer by sex and country. Nordic cancer survival study 1964–2003.

Figure 2. Trends in age-standardised (ICSS) excess death rates per 100 person years for oesophageal cancer by sex, country, and time since diagnosis. Nordic cancer survival study 1964–2003.

Table I. Trends in survival for oesophageal cancer by sex and country. Number of tumours (N) included and the 5-year age-standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
Men
1964–1968	403	6 (4–9)	588	5 (3–7)	28	0 (·-·)	369	4 (2–8)	826	5 (3–7)
1969–1973	473	3 (1–5)	527	5 (3–8)	22	0 (·-·)	377	2 (1–4)	955	7 (4–10)
1974–1978	500	1 (1–4)	458	5 (3–8)	25	14 (6–35)	439	4 (2–6)	943	5 (4–7)
1979–1983	554	6 (4–10)	489	7 (5–11)	32	14 (6–35)	430	3 (2–6)	1 050	5 (4–7)
1984–1988	750	2 (1–4)	496	7 (5–11)	28	18 (10–34)	443	4 (2–6)	1 114	6 (4–8)
1989–1993	959	4 (3–5)	544	6 (4–8)	47	18 (10–34)	518	4 (3–7)	1 113	8 (6–10)
1994–1998	1 177	4 (3–6)	600	7 (5–10)	59	12 (7–21)	544	8(5–11)	1 183	11 (9–14)
1999–2003	1 352	6 (5–7)	704	9 (7–11)	46	12 (7–21)	605	8 (6–11)	1 355	11 (10–13)
Women
1964–1968	246	6 (3–10)	704	5 (4–8)	28	8 (2–34)	149	6 (3–14)	457	9 (6–14)
1969–1973	246	10 (6–16)	628	8 (6–11)	15	8 (2–34)	141	3 (1–8)	437	10 (7–15)
1974–1978	286	5 (3–10)	582	8 (6–12)	18	9 (3–27)	167	7 (4–12)	400	6 (4–10)
1979–1983	303	7 (4–11)	593	10 (7–14)	25	9 (3–27)	148	12 (7–22)	392	10 (7–14)
1984–1988	337	8 (5–13)	558	11 (8–15)	16	27 (12–58)	177	6 (3–13)	446	14 (10–19)
1989–1993	385	10 (7–15)	442	11 (7–16)	21	27 (12–58)	184	11 (7–18)	536	12 (9–17)
1994–1998	467	4 (3–7)	470	19 (15–25)	23	9 (3–25)	220	8 (5–14)	487	15 (11–20)
1999–2003	519	7 (5–10)	380	20 (16–25)	16	9 (3–25)	253	9 (6–13)	575	14 (11–17)

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

0(·-·) No patients survived five years.

Table II. Trends in 5-year age-specific relative survival in percent after oesophageal cancer by sex and country. Nordic cancer survival study 1964–2003.

	Men						Women
Age	0–49	50–59	60–69	70–79	80–89	90+	0–49	50–59	60–69	70–79	80–89	90+
Denmark
1964–1968	13	14	2	3	4	*	0	0	12	7	3	0
1969–1973	0	5	2	4	0	0	17	17	6	11	0	0
1974–1978	7	1	1	1	0	0	6	6	7	5	2	0
1979–1983	7	3	7	6	9	0	10	10	10	5	0	0
1984–1988	8	2	2	1	0	0	12	12	6	7	6	0
1989–1993	6	5	6	1	0	0	17	17	11	8	2	0
1994–1998	4	7	7	2	0	0	8	8	4	3	2	0
1999–2003	8	8	8	3	1	0	11	11	11	2	5	0
Finland
1964–1968	21	4	3	2	0	*	10	10	6	3	0	0
1969–1973	16	3	6	4	0	*	15	15	11	4	0	0
1974–1978	12	9	6	1	0	0	14	14	9	5	1	0
1979–1983	27	7	7	4	0	*	22	22	6	6	3	0
1984–1988	12	9	10	6	0	0	13	13	14	9	3	0
1989–1993	6	7	6	8	0	0	17	17	15	5	3	0
1994–1998	8	8	10	8	0	*	33	33	24	9	3	0
1999–2003	14	10	8	9	3	0	30	30	29	9	4	0
Iceland
1964–1968	0	0	0	*	0	*	11	11	11	8	*	*
1969–1973	0	0	0	*	0	*	11	11	11	8	*	*
1974–1978	21	21	19	11	*	*	13	13	13	0	11	*
1979–1983	21	21	19	11	*	*	13	13	13	0	11	*
1984–1988	26	26	19	20	*	*	40	40	40	15	0	*
1989–1993	26	26	19	20	*	*	40	40	40	15	0	*
1994–1998	18	18	10	7	13	*	7	7	7	19	0	*
1999–2003	18	18	10	7	13	*	7	7	7	19	*	*
Norway
1964–1968	9	5	2	1	5	*	6	6	6	6	6	0
1969–1973	0	6	1	3	0	*	0	0	0	7	7	*
1974–1978	0	5	4	3	4	119	0	0	19	5	0	*
1979–1983	0	4	5	2	7	0	19	19	7	7	16	0
1984–1988	0	2	5	5	3	0	6	6	10	6	0	0
1989–1993	4	5	4	6	0	*	8	8	13	14	7	0
1994–1998	13	10	7	7	4	0	7	7	14	5	5	0
1999–2003	20	8	8	6	3	0	10	10	10	9	6	0
Sweden
1964–1968	9	5	5	2	4	0	16	15	9	8	2	0
1969–1973	23	6	3	4	4	0	20	19	11	2	6	0
1974–1978	6	5	6	6	2	0	0	6	10	7	4	0
1979–1983	8	6	4	8	0	*	0	16	12	13	3	0
1984–1988	13	4	8	3	4	0	34	31	3	9	6	0
1989–1993	12	9	7	9	0	0	17	11	17	11	2	0
1994–1998	23	11	12	10	3	0	20	19	14	16	4	0
1999–2003	20	12	13	10	4	29	28	22	9	13	1	0

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

*Too few patients to calculate survival, see ref. [18].

Figure 3. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5-year relative survival for stomach cancer by sex and country. Nordic cancer survival study 1964–2003.

Figure 4. Trends in age-standardised (ICSS) excess death rates per 100 person years for stomach cancer by sex, country, and time since diagnosis. Nordic cancer survival study 1964–2003.

Table III. Trends in survival for stomach cancer by sex and country. Number of tumours (N) included and the 5-year age-standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
Men
1964–1968	3 402	12 (11–13)	4 292	7 (7–8)	223	14 (9–21)	3 853	11 (10–13)	7 066	11 (11–12)
1969–1973	3 389	11 (10–12)	3 717	11 (10–12)	210	12 (8–19)	3 324	13 (12–14)	6 470	12 (11–13)
1974–1978	3 037	11 (10–12)	3 323	13 (11–14)	191	16 (11–23)	3 051	17 (16–19)	5 546	13 (12–14)
1979–1983	2 777	12 (10–13)	3 085	16 (15–18)	192	24 (19–32)	2 939	18 (17–20)	5 148	16 (15–18)
1984–1988	2 271	12 (11–14)	2 886	20 (18–22)	189	17 (11–24)	2 661	19 (17–21)	4 613	18 (16–19)
1989–1993	1 785	13 (12–15)	2 501	21 (19–23)	173	30 (23–40)	2 437	19 (17–21)	4 172	18 (17–20)
1994–1998	1 628	13 (12–15)	2 291	24 (22–26)	129	26 (19–37)	2 077	18 (16–20)	3 497	20 (18–22)
1999–2003	1 578	14 (12–15)	2 006	26 (24–27)	111	22 (16–31)	1 766	20 (18–22)	3 039	20 (18–21)
Women
1964–1968	2 061	11 (9–12)	3 329	7 (6–9)	111	10 (5–18)	2 483	10 (9–12)	4 419	12 (11–14)
1969–1973	2 121	11 (9–12)	2 925	12 (10–13)	97	21 (13–33)	2 140	11 (10–13)	4 123	13 (12–14)
1974–1978	1 995	12 (10–14)	2 702	13 (12–15)	107	22 (14–33)	1 978	16 (14–18)	3 520	15 (13–16)
1979–1983	1 730	14 (12–16)	2 779	18 (16–20)	94	32 (22–45)	1 982	21 (19–23)	3 182	17 (16–19)
1984–1988	1 504	14 (12–17)	2 658	20 (18–22)	88	41 (30–54)	1 801	23 (21–25)	3 036	20 (19–22)
1989–1993	1 214	16 (14–19)	2 234	24 (22–27)	103	27 (18–39)	1 558	23 (21–26)	2 612	20 (18–22)
1994–1998	1 008	15 (13–18)	1 962	30 (28–33)	67	29 (19–46)	1 370	25 (22–28)	2 220	23 (21–25)
1999–2003	891	14 (12–16)	1 660	30 (28–33)	73	43 (33–56)	1 136	24 (22–27)	2 015	24 (22–26)

Table IV. Trends in 5-year age-specific relative survival in percent after stomach cancer by sex and country. Nordic cancer survival study 1964–2003.

	Men						Women
Age	0–49	50–59	60–69	70–79	80–89	90+	0–49	50–59	60–69	70–79	80–89	90+
Denmark
1964–1968	19	14	12	11	7	0	11	13	11	11	7	0
1969–1973	16	13	11	9	7	0	9	12	12	10	8	23
1974–1978	20	13	12	9	5	0	19	13	10	13	7	0
1979–1983	15	15	14	8	7	0	25	17	14	12	7	12
1984–1988	12	19	13	11	6	11	9	19	17	15	7	0
1989–1993	20	15	15	12	7	0	14	19	24	12	7	0
1994–1998	16	20	14	11	7	0	22	27	15	9	8	0
1999–2003	19	16	15	12	7	13	11	20	18	10	8	1
Finland
1964–1968	12	14	8	5	0	0	13	9	8	5	4	0
1969–1973	15	17	10	9	4	39	19	17	11	10	5	0
1974–1978	19	16	15	10	5	0	19	18	14	9	7	0
1979–1983	19	28	17	12	7	0	29	23	18	15	8	7
1984–1988	27	25	22	17	11	0	29	28	22	16	9	0
1989–1993	24	33	20	17	12	0	31	29	28	22	12	0
1994–1998	29	28	24	24	15	19	41	37	33	24	21	18
1999–2003	29	26	27	26	18	13	38	44	34	24	17	11
Iceland
1964–1968	23	23	12	9	12	*	6	6	15	12	*	*
1969–1973	19	19	11	8	10	0	26	26	16	24	14	*
1974–1978	17	17	13	23	6	*	26	26	17	30	6	*
1979–1983	28	28	39	19	*	*	51	51	31	29	*	*
1984–1988	20	20	26	10	7	0	68	68	46	17	24	0
1989–1993	38	38	35	15	37	0	27	27	24	40	6	0
1994–1998	34	34	26	24	16	*	28	28	29	34	23	0
1999–2003	25	25	21	27	12	*	49	49	47	48	12	0
Norway
1964–1968	15	14	13	10	7	0	11	13	14	9	4	0
1969–1973	17	17	13	10	9	0	10	15	12	11	7	0
1974–1978	23	25	18	13	10	0	22	20	14	17	8	0
1979–1983	29	26	17	16	10	0	33	24	22	17	13	0
1984–1988	22	23	22	15	14	0	31	27	23	22	13	13
1989–1993	26	23	22	17	8	24	28	27	25	20	19	14
1994–1998	17	21	22	17	10	0	26	23	31	23	21	24
1999–2003	27	26	22	15	11	0	34	22	27	21	20	8
Sweden
1964–1968	13	17	11	10	7	0	14	11	14	13	11	6
1969–1973	15	15	12	10	7	0	12	18	11	13	10	0
1974–1978	18	18	13	11	6	0	19	17	17	13	9	12
1979–1983	26	18	18	13	9	0	21	17	20	16	11	5
1984–1988	23	22	19	15	11	0	28	23	24	16	14	0
1989–1993	21	25	20	16	11	0	28	24	18	21	12	4
1994–1998	24	23	22	18	14	0	30	25	27	19	16	4
1999–2003	23	25	21	19	11	7	29	23	28	22	15	1

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

*Too few patients to calculate survival, see ref. [18].

Figure 5. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5-year relative survival for cancer of small intestine by sex and country. Nordic cancer survival study 1964–2003.

Figure 6. Trends in age-standardised (ICSS) excess death rates per 100 person years for cancer of small intestine by sex, country, and time since diagnosis. Nordic cancer survival study 1964–2003. No Icelandic curves. Too few patients to calculate survival for Iceland.

Table V. Trends in survival for cancer of small intestine by sex and country. Number of tumours (N) included and the 5-year age-standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
Men
1964–1968	109	17 (11–26)	50	42 (25–70)	0	*	60	31 (23–41)	280	26 (21–32)
1969–1973	134	19 (13–28)	68	42 (25–70)	8	*	69	31 (23–41)	313	26 (22–32)
1974–1978	165	19 (14–27)	72	37 (28–49)	7	*	86	29 (18–47)	296	40 (33–47)
1979–1983	153	22 (16–32)	104	37 (28–49)	6	*	116	40 (30–52)	336	43 (37–51)
1984–1988	151	24 (17–34)	139	52 (40–68)	8	*	132	32 (24–44)	475	40 (35–45)
1989–1993	125	30 (22–41)	149	42 (32–54)	8	*	143	45 (35–56)	448	44 (38–50)
1994–1998	149	35 (26–46)	167	43 (35–53)	7	*	187	50 (42–61)	482	50 (45–55)
1999–2003	148	35 (28–44)	202	54 (47–61)	16	*	244	48 (42–55)	558	52 (48–56)
Women
1964–1968	83	18 (11–30)	56	35 (28–44)	0	*	46	33 (24–44)	264	32 (26–38)
1969–1973	113	26 (19–37)	77	35 (28–44)	3	*	78	33 (24–44)	299	37 (32–44)
1974–1978	143	22 (16–30)	87	42 (33–54)	7	*	91	45 (32–62)	277	36 (30–43)
1979–1983	146	24 (18–33)	101	53 (42–67)	3	*	120	39 (30–50)	301	48 (42–55)
1984–1988	112	19 (12–29)	132	38 (30–48)	3	*	135	32 (24–42)	392	42 (37–47)
1989–1993	134	27 (19–37)	153	38 (31–47)	7	*	157	40 (33–50)	397	48 (43–54)
1994–1998	136	19 (13–28)	159	47 (39–56)	13	*	155	47 (39–57)	468	47 (42–52)
1999–2003	151	35 (28–43)	174	49 (43–56)	10	*	242	55 (49–61)	427	51 (47–55)

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

*Too few patients to calculate survival, see ref. [18].

Table VI. Trends in 5-year age-specific relative survival in percent after cancer of small intestine by sex and country. Nordic cancer survival study 1964–2003.

	Men						Women
Age	0–49	50–59	60–69	70–79	80–89	90+	0–49	50–59	60–69	70–79	80–89	90+
Denmark
1964–1968	46	12	17	17	0	*	30	24	21	18	0	*
1969–1973	36	37	14	8	14	*	40	35	34	22	0	*
1974–1978	11	32	30	16	0	*	42	52	28	3	0	*
1979–1983	41	21	25	18	12	*	34	33	22	24	11	*
1984–1988	25	30	26	19	21	*	23	15	31	11	14	*
1989–1993	77	41	7	24	35	*	36	35	25	23	20	*
1994–1998	44	50	33	16	48	*	23	19	30	12	12	*
1999–2003	58	48	22	26	41	*	56	38	43	25	19	11
Finland
1964–1968	41	50	32	34	69	*	60	33	37	41	0	*
1969–1973	41	50	32	34	69	*	60	33	37	41	0	*
1974–1978	45	43	32	42	23	*	54	64	48	41	0	*
1979–1983	45	43	32	42	23	*	74	51	45	48	63	*
1984–1988	68	47	40	33	103	*	50	32	56	33	9	*
1989–1993	44	55	39	33	46	*	63	60	43	27	8	*
1994–1998	52	56	43	46	16	*	67	67	48	36	26	0
1999–2003	77	63	64	45	23	*	67	63	50	47	21	0
Iceland
1964–1968	23	23	23	*	*	*	*	*	*	*		*
1969–1973	23	23	23	*	*	*	*	*	*	*	*	*
1974–1978	41	41	41	24	*	*	*	*	*	*	*	*
1979–1983	41	41	41	24	*	*	*	*	*	*	*	*
1984–1988	88	88	88	*	*	*	*	*	*	*	*	*
1989–1993	88	88	88	*	*	*	*	*	*	*	*	*
1994–1998	62	62	62	19	*	*	70	70	70	*	*	*
1999–2003	62	62	62	19	*	*	70	70	70	*	*	*
Norway
1964–1968	42	37	29	40	0	*	61	33	40	20	22	*
1969–1973	42	37	29	40	0	*	61	33	40	20	22	*
1974–1978	31	25	35	5	65	*	78	32	48	22	69	*
1979–1983	41	38	59	29	28	*	54	51	34	37	25	*
1984–1988	59	41	21	21	43	*	36	37	48	24	10	*
1989–1993	46	41	52	44	35	*	62	47	36	38	28	*
1994–1998	64	48	51	43	54	*	64	31	63	36	45	*
1999–2003	45	62	54	44	34	*	61	63	65	47	38	48
Sweden
1964–1968	34	51	28	15	7	*	43	50	34	21	19	*
1969–1973	47	44	22	23	5	*	65	44	32	33	24	*
1974–1978	58	41	38	43	19	*	61	28	40	34	23	*
1979–1983	59	47	48	45	15	*	63	46	47	52	34	*
1984–1988	60	61	46	24	21	*	61	54	40	36	26	0
1989–1993	48	59	43	33	44	105	56	54	55	41	37	73
1994–1998	60	59	55	44	31	118	67	54	51	43	23	0
1999–2003	64	61	51	47	44	55	76	61	53	45	27	0

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

*Too few patients to calculate survival, see ref. [18].

Figure 7. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5-year relative survival for colon cancer by sex and country. Nordic cancer survival study 1964–2003.

Figure 8. Trends in age-standardised (ICSS) excess death rates per 100 person years for colon cancer by sex, country, and time since diagnosis. Nordic cancer survival study 1964–2003.

Table VII. Trends in survival for colon cancer by sex and country. Number of tumours (N) included and the 5-year age-standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
Men
1964–1969	2 556	31 (29–34)	750	24 (21–28)	54	41 (27–61)	1 708	33 (30–35)	4 719	35 (33–37)
1969–1973	3 125	30 (28–32)	940	35 (31–40)	67	41 (28–60)	1 803	38 (35–41)	5 318	36 (35–38)
1974–1978	3 695	34 (32–36)	1 103	37 (33–41)	84	47 (36–61)	2 314	42 (40–45)	5 323	39 (37–41)
1979–1983	3 737	37 (35–39)	1 501	48 (45–51)	128	47 (38–58)	2 915	47 (45–50)	5 777	46 (44–48)
1984–1988	4 137	39 (37–41)	1 836	47 (44–50)	152	42 (33–53)	3 443	46 (44–48)	6 337	48 (47–50)
1989–1993	4 275	43 (41–45)	2 099	51 (48–54)	145	57 (48–68)	3 988	49 (47–51)	6 802	52 (50–53)
1994–1998	4 521	45 (43–47)	2 651	57 (54–59)	203	51 (43–61)	4 322	53 (51–55)	7 214	55 (54–57)
1999–2003	5 199	49 (47–50)	2 969	59 (57–61)	238	55 (49–62)	4 784	55 (54–57)	7 761	56 (55–57)
Women
1964–1969	3 269	33 (31–35)	1 169	30 (27–33)	67	32 (21–50)	1 946	34 (32–37)	4 919	38 (37–40)
1969–1973	3 791	35 (33–36)	1 496	35 (33–38)	93	36 (26–48)	2 215	39 (37–42)	5 690	39 (37–40)
1974–1978	4 530	35 (34–37)	1 827	40 (37–42)	106	53 (43–65)	2 890	42 (40–45)	5 760	42 (40–43)
1979–1983	4 955	41 (39–43)	2 342	46 (43–48)	114	54 (43–66)	3 602	47 (45–49)	6 591	49 (47–50)
1984–1988	5 172	43 (41–44)	2 675	51 (48–53)	138	49 (40–60)	4 117	51 (49–53)	7 068	52 (51–54)
1989–1993	5 314	46 (45–48)	3 042	53 (51–56)	150	61 (52–71)	4 483	53 (52–55)	7 537	54 (53–56)
1994–1998	5 447	48 (47–50)	3 399	57 (55–59)	172	50 (42–60)	5 237	57 (55–58)	7 706	56 (55–58)
1999–2003	5 660	52 (51–53)	3 679	62 (61–64)	183	58 (51–65)	5 664	59 (57–60)	8 248	60 (59–61)

Table VIII. Trends in 5-year age-specific relative survival in percent after colon cancer by sex and country. Nordic cancer survival study 1964–2003.

	Men						Women
Age	0–49	50–59	60–69	70–79	80–89	90+	0–49	50–59	60–69	70–79	80–89	90+
Denmark
1964–1968	46	37	30	30	17	0	38	37	36	30	26	13
1969–1973	46	38	30	28	15	0	42	37	38	31	25	49
1974–1978	45	33	36	31	30	0	41	40	40	34	20	16
1979–1983	44	41	39	35	27	12	44	47	44	37	34	20
1984–1988	45	46	41	34	34	31	46	45	46	40	37	37
1989–1993	53	41	45	42	36	39	49	50	49	45	39	34
1994–1998	55	45	45	43	40	39	53	51	50	47	43	46
1999–2003	58	47	52	46	43	24	59	53	53	50	47	42
Finland
1964–1968	39	29	29	21	4	*	45	43	30	21	19	0
1969–1973	50	42	39	29	22	*	56	43	36	30	20	0
1974–1978	50	37	36	36	30	58	58	44	42	35	26	0
1979–1983	59	54	48	50	28	0	66	46	45	43	34	21
1984–1988	54	52	47	42	43	112	73	56	50	45	38	14
1989–1993	63	53	48	48	50	0	73	58	52	48	44	21
1994–1998	68	57	57	55	51	61	71	62	58	55	45	34
1999–2003	68	57	59	59	54	62	73	66	60	62	53	32
Iceland
1964–1968	40	40	58	16	58	*	31	31	46	15	46	*
1969–1973	37	37	34	46	50	*	47	47	26	35	32	*
1974–1978	58	58	63	39	14	*	74	74	51	40	41	*
1979–1983	70	70	59	31	10	*	51	51	49	50	73	*
1984–1988	44	44	45	39	38	*	51	51	55	39	54	0
1989–1993	67	67	57	47	58	109	62	62	66	47	77	137
1994–1998	46	46	55	50	54	63	54	54	43	55	49	91
1999–2003	62	62	66	49	35	128	57	57	63	57	49	101
Norway
1964–1968	50	33	34	30	21	0	39	44	38	30	21	0
1969–1973	37	40	35	37	41	0	51	41	44	36	28	15
1974–1978	56	47	41	42	29	20	54	44	44	40	34	0
1979–1983	56	52	48	45	40	45	51	51	48	49	33	39
1984–1988	52	47	50	45	34	35	54	55	53	51	41	45
1989–1993	44	47	54	47	50	31	57	56	54	54	45	36
1994–1998	55	54	54	52	49	36	58	54	63	55	50	43
1999–2003	57	58	58	52	49	36	60	60	63	57	52	31
Sweden
1964–1968	47	43	36	30	23	20	57	42	40	32	28	23
1969–1973	48	43	37	32	25	6	49	46	42	35	24	14
1974–1978	43	43	41	37	31	15	43	46	44	41	33	15
1979–1983	51	47	48	47	36	30	51	49	50	48	46	21
1984–1988	50	49	48	48	48	56	58	53	52	50	49	38
1989–1993	54	52	51	51	52	50	57	52	53	56	52	38
1994–1998	57	57	56	55	51	39	57	55	56	56	56	65
1999–2003	61	56	55	56	52	72	62	60	60	58	61	60

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

*Too few patients to calculate survival, see ref. [18].

Figure 9. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5-year relative survival for rectal and anal cancer by sex and country. Nordic cancer survival study 1964–2003.

Table IX. Trends in survival for rectal and anal cancer by sex and country. Number of tumours (N) included and the 5-year age-standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
Men
1964–1968	2 715	31 (28–33)	791	24 (21–28)	39	32 (21–51)	1 041	27 (24–31)	3 263	33 (31–35)
1969–1973	3 024	32 (30–34)	991	30 (27–34)	37	25 (12–49)	1 451	32 (29–35)	3 522	35 (34–38)
1974–1978	3 266	34 (32–36)	1 220	38 (35–42)	50	34 (22–53)	1 906	37 (35–40)	3 908	38 (36–40)
1979–1983	3 531	35 (33–37)	1 440	40 (37–43)	51	35 (22–53)	2 420	44 (41–47)	4 224	43 (41–45)
1984–1988	3 470	37 (35–39)	1 550	49 (46–52)	61	58 (44–76)	2 606	45 (42–47)	4 518	46 (45–48)
1989–1993	3 562	41 (39–43)	1 800	46 (44–49)	42	54 (38–77)	2 797	48 (46–50)	4 799	51 (49–53)
1994–1998	3 648	45 (43–47)	2 039	54 (51–57)	68	47 (35–62)	2 941	56 (53–58)	4 990	54 (52–56)
1999–2003	3 892	49 (48–51)	2 289	57 (55–59)	77	65 (55–76)	3 171	57 (56–59)	5 339	57 (56–58)
Women
1964–1968	2 030	31 (29–34)	1 010	30 (27–34)	30	45 (32–64)	856	29 (25–32)	2 395	37 (35–39)
1969–1973	2 280	35 (33–37)	1 131	37 (33–40)	42	45 (32–64)	1 212	37 (34–40)	2 680	41 (39–43)
1974–1978	2 484	38 (36–40)	1 331	41 (38–44)	35	44 (29–68)	1 558	42 (40–45)	2 882	43 (41–45)
1979–1983	2 845	41 (39–43)	1 503	44 (41–47)	43	58 (43–79)	1 977	48 (46–51)	3 501	47 (45–49)
1984–1988	2 705	41 (39–43)	1 655	48 (45–51)	47	39 (26–57)	2 078	51 (48–53)	3 719	53 (51–54)
1989–1993	2 793	43 (41–46)	1 729	50 (48–53)	51	61 (48–79)	2 341	57 (54–59)	4 063	55 (54–57)
1994–1998	3 041	50 (48–52)	1 950	55 (52–58)	60	41 (29–56)	2 474	60 (57–62)	4 046	61 (59–63)
1999–2003	3 024	53 (51–54)	2 070	60 (58–62)	81	52 (43–64)	2 553	63 (61–65)	4 290	62 (61–64)

Figure 10. Trends in age-standardised (ICSS) excess death rates per 100 person years for rectal and anal cancer by sex, country, and time since diagnosis. Nordic cancer survival study 1964–2003.

Table X. Trends in 5-year age-specific relative survival in percent after rectal and anal cancer by sex and country. Nordic cancer survival study 1964–2003.

	Men						Women
Age	0–49	50–59	60–69	70–79	80–89	90+	0–49	50–59	60–69	70–79	80–89	90+
Denmark
1964–1968	43	35	35	25	17	0	40	37	35	29	16	21
1969–1973	42	37	34	30	19	0	44	39	40	31	20	0
1974–1978	33	40	39	35	19	13	49	47	42	33	23	0
1979–1983	42	38	40	34	20	20	50	48	42	40	26	7
1984–1988	39	44	36	38	29	42	45	50	47	39	23	12
1989–1993	48	43	46	38	30	12	52	47	46	40	33	20
1994–1998	52	46	47	44	34	28	57	57	54	47	36	24
1999–2003	52	54	53	47	39	32	61	59	56	50	37	28
Finland
1964–1968	38	29	34	18	4	0	41	37	35	25	16	*
1969–1973	37	46	36	22	11	0	41	44	46	29	21	0
1974–1978	48	48	40	35	22	0	45	62	43	37	18	0
1979–1983	50	44	45	38	23	0	52	48	49	47	17	39
1984–1988	52	50	51	47	46	0	66	53	50	43	33	24
1989–1993	52	48	48	47	37	39	67	53	53	48	34	33
1994–1998	59	57	56	53	47	18	66	69	58	50	36	32
1999–2003	64	59	60	55	48	52	73	68	64	56	44	25
Iceland
1964–1968	52	52	52	12	*	*	36	36	48	37	76	*
1969–1973	22	22	22	22	40	*	36	36	48	37	76	*
1974–1978	38	38	38	34	19	*	62	62	36	56	*	*
1979–1983	45	45	45	23	16	*	65	65	64	61	31	*
1984–1988	67	67	67	46	47	*	56	56	47	25	17	*
1989–1993	52	52	52	70	31	*	71	71	63	67	27	*
1994–1998	55	55	55	43	21	*	66	66	37	21	37	*
1999–2003	73	73	73	52	59	*	65	65	64	33	43	*
Norway
1964–1968	39	33	30	24	13	0	41	32	38	22	11	0
1969–1973	37	37	34	27	29	0	37	47	44	31	25	0
1974–1978	48	43	43	33	21	21	52	49	48	40	22	0
1979–1983	56	46	46	41	35	18	64	62	49	44	28	26
1984–1988	53	52	48	40	32	0	57	62	57	43	38	22
1989–1993	51	54	52	48	33	24	63	69	60	52	40	6
1994–1998	60	62	57	56	42	28	64	69	64	58	42	53
1999–2003	63	64	60	55	47	33	70	71	65	60	50	33
Sweden
1964–1968	43	39	38	28	15	0	49	48	39	34	18	15
1969–1973	45	41	39	30	26	19	60	48	46	35	21	13
1974–1978	49	42	42	34	25	11	52	53	47	40	25	11
1979–1983	53	42	45	43	33	8	62	51	49	44	31	23
1984–1988	54	47	49	45	38	34	62	62	54	48	40	17
1989–1993	54	53	54	51	39	8	59	61	59	54	44	44
1994–1998	55	61	54	54	46	53	70	68	63	58	48	36
1999–2003	61	63	58	54	50	40	72	68	66	58	51	35

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

*Too few patients to calculate survival, see ref. [18].

Figure 11. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5-year relative survival for liver cancer by sex and country. Nordic cancer survival study 1964–2003.

Figure 12. Trends in age-standardised (ICSS) excess death rates per 100 person years for liver cancer by sex, country, and time since diagnosis. Nordic cancer survival study 1964–2003.

Table XI. Trends in survival for liver cancer by sex and country. Number of tumours (N) included and the 5-year age-standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
Men
1964–1968	376	1 (0–3)	146	0 (·-·)	12	*	145	0 (·-·)	1 041	2 (1–3)
1969–1973	487	0 (0–1)	244	0 (0–3)	14	*	205	1 (0–4)	1 312	3 (2–4)
1974–1978	590	1 (0–2)	328	2 (1–5)	13	*	252	6 (4–11)	1 042	2 (1–4)
1979–1983	577	2 (1–4)	395	2 (1–5)	13	*	254	1 (0–4)	1 135	1 (1–2)
1984–1988	633	2 (1–4)	525	5 (4–8)	18	14 (6–35)	311	3 (1–5)	1 283	3 (2–5)
1989–1993	615	3 (2–5)	535	4 (3–7)	18	14 (6–35)	289	6 (4–9)	1 350	5 (4–7)
1994–1998	660	4 (2–6)	669	7 (5–10)	28	7 (3–21)	268	5 (3–8)	1 366	6 (5–8)
1999–2003	852	3 (2–4)	670	8 (6–10)	16	7 (3–21)	368	5 (4–8)	1 292	7 (6–8)
Women
1964–1968	269	1 (0–4)	128	1 (0–6)	8	*	71	7 (3–15)	655	2 (1–5)
1969–1973	320	1 (0–4)	199	0 (0–3)	8	*	130	6 (3–12)	896	3 (2–5)
1974–1978	445	1 (0–3)	258	3 (2–7)	14	*	140	3 (1–8)	850	3 (2–5)
1979–1983	478	2 (1–4)	359	3 (2–6)	15	*	170	3 (1–8)	856	3 (2–5)
1984–1988	444	4 (2–7)	456	5 (3–9)	7	*	205	10 (6–17)	995	3 (2–5)
1989–1993	475	3 (1–5)	492	5 (3–8)	11	*	219	8 (5–13)	1 087	3 (2–5)
1994–1998	453	4 (2–6)	437	7 (4–11)	10	*	165	11 (6–18)	1 047	7 (5–9)
1999–2003	511	5 (3–7)	464	8 (6–11)	8	*	237	11 (8–16)	852	8 (6–9)

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

*Too few patients to calculate survival, see ref. [18]. 0 (·-·) No patients survived five years.

Table XII. Trends in 5-year age-specific relative survival in percent after liver cancer by sex and country. Nordic cancer survival study 1964–2003.

	Men						Women
Age	0–49	50–59	60–69	70–79	80–89	90+	0–49	50–59	60–69	70–79	80–89	90+
Denmark
1964–1968	9	0	0	0	0	*	5	0	0	3	0	*
1969–1973	0	0	1	0	0	*	0	2	1	0	3	*
1974–1978	5	0	0	1	0	0	0	2	2	0	2	*
1979–1983	9	0	1	2	0	0	3	2	1	2	2	0
1984–1988	7	1	2	0	2	0	24	2	2	0	0	0
1989–1993	16	0	2	2	0	0	5	7	2	2	0	0
1994–1998	16	4	3	0	3	0	8	6	4	2	0	0
1999–2003	7	5	3	1	1	0	18	8	5	0	1	0
Finland
1964–1968	0	0	0	0	0	*	7	0	2	0	0	*
1969–1973	3	0	0	0	0	*	4	0	0	0	0	*
1974–1978	10	2	0	2	0	*	5	3	5	3	0	0
1979–1983	8	2	2	2	0	*	8	3	4	2	0	0
1984–1988	26	3	3	4	0	0	17	7	5	3	0	0
1989–1993	16	7	2	2	0	61	21	5	2	4	0	0
1994–1998	14	4	7	7	4	0	7	18	6	4	0	0
1999–2003	14	7	8	6	5	0	14	11	9	5	2	0
Iceland
1964–1968	0	0	0	0	*	*	*	*	*	*	*	*
1969–1973	0	0	0	0	*	*	*	*	*	*	*	*
1974–1978	0	0	0	0	0	*	30	30	30	*	*	*
1979–1983	0	0	0	0	0	*	30	30	30	*	*	*
1984–1988	12	12	12	26	0	*	11	11	11	*	*	*
1989–1993	12	12	12	26	0	*	11	11	11	*	*	*
1994–1998	10	10	10	7	0	*	8	8	8	*	*	*
1999–2003	10	10	10	7	0	*	8	8	8	*	*	*
Norway
1964–1968	0	0	0	0	0	*	34	0	10	0	0	*
1969–1973	8	3	0	0	0	*	16	0	12	2	0	*
1974–1978	29	0	3	3	8	*	13	6	0	0	0	*
1979–1983	4	0	0	2	0	*	14	0	0	0	6	*
1984–1988	13	0	2	1	0	0	33	14	9	5	0	0
1989–1993	34	0	3	4	0	*	37	9	4	3	0	*
1994–1998	19	3	2	5	0	*	37	11	13	2	0	0
1999–2003	17	7	4	3	0	0	34	12	12	6	0	0
Sweden
1964–1968	5	2	1		1	0	4	5	1	1	4	0
1969–1973	15	1	2		0	0	9	5	1	2	2	16
1974–1978	7	1	3		0	0	8	6	1	3	0	0
1979–1983	5	2	0		0	0	13	1	2	2	0	0
1984–1988	10	4	1		2	0	11	4	3	2	1	0
1989–1993	18	7	3	2	2	0	10	3	2	2	0	0
1994–1998	19	7	5	2	3	0	24	8	4	4	2	0
1999–2003	20	9	6	3	4	0	26	12	4	3	4	0

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

*Too few patients to calculate survival, see ref. [18].

Figure 13. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5-year relative survival for cancer of the gallbladder and extrahepatic biliary ducts by sex and country. Nordic cancer survival study 1964–2003.

Figure 14. Trends in age-standardised (ICSS) excess death rates per 100 person years for cancer of the gallbladder and extrahepatic bilary ducts by sex, country, and time since diagnosis. Nordic cancer survival study 1964–2003.

Table XIII. Trends in survival for cancer of gallbladder and extrahepatic biliary ducts by sex and country. Number of tumours (N) included and the 5-year age-standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
Men
1964–1968	325	4 (2–7)	120	5 (3–8)	2	*	127	4 (2–9)	681	5 (3–8)
1969–1973	423	2 (1–5)	171	5 (3–8)	6	*	128	4 (2–9)	789	6 (4–9)
1974–1978	429	5 (3–8)	209	9 (5–14)	9	*	179	10 (5–19)	842	8 (6–11)
1979–1983	381	6 (3–10)	314	6 (3–10)	10	*	172	8 (4–15)	883	6 (4–8)
1984–1988	369	7 (5–12)	347	7(5–11)	10	*	226	15 (10–21)	976	9 (7–12)
1989–1993	345	8 (5–12)	335	10 (7–14)	12	*	198	12 (8–20)	861	10 (8–13)
1994–1998	317	10 (7–14)	394	9 (6–13)	12	17 (8–38)	275	12 (8–18)	729	12 (10–16)
1999–2003	319	10 (8–14)	378	13 (10–17)	17	17 (8–38)	275	14 (11–19)	656	13 (11–16)
Women
1964–1968	647	2 (1–4)	343	3 (1–5)	10	*	262	4 (2–7)	1 458	4 (3–5)
1969–1973	889	5 (3–8)	479	5 (3–8)	15	*	274	8 (5–13)	1 852	5 (3–6)
1974–1978	930	4 (3–7)	682	5 (3–8)	11	12 (2–58)	283	7 (5–12)	1 838	4 (3–6)
1979–1983	839	6 (4–9)	892	7 (6–10)	10	12 (2–58)	369	12 (9–18)	1 921	6 (5–8)
1984–1988	752	5 (3–7)	997	9 (7–12)	18	31 (17–56)	373	21 (16–28)	2 030	5 (4–7)
1989–1993	603	8(5–11)	895	9 (7–12)	19	31 (17–56)	307	10 (6–17)	1 772	9 (7–10)
1994–1998	477	7 (4–11)	888	13 (10–16)	30	29 (17–48)	363	13 (9–19)	1 381	9 (7–11)
1999–2003	460	11 (8–16)	836	12 (10–14)	14	29 (17–48)	381	12 (9–16)	1 154	10 (9–12)

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

*Too few patients to calculate survival, see ref. [18].

Table XIV. Trends in 5-year age-specific relative survival in percent after cancer of gallbladder and extrahepatic biliary ducts by sex and country. Nordic cancer survival study 1964–2003.

	Men						Women
Age	0–49	50–59	60–69	70–79	80–89	90+	0–49	50–59	60–69	70–79	80–89	90+
Denmark
1964–1968	4	14	3	0	0	*	0	4	2	2	2	0
1969–1973	0	10	1	1	0	0	11	8	5	4	1	0
1974–1978	9	7	4	3	3	0	11	4	5	3	2	0
1979–1983	11	8	7	2	4	*	14	9	7	4	1	0
1984–1988	24	10	2	6	4	0	5	8	5	2	5	0
1989–1993	13	8	9	6	3	*	18	12	6	5	2	0
1994–1998	0	24	8	10	4	*	17	10	6	3	1	15
1999–2003	10	17	13	9	1	0	29	23	10	3	3	31
Finland
1964–1968	7	5	8	3	0	*	0	6	5	1	0	*
1969–1973	7	5	8	3	0	*	13	8	5	4	0	*
1974–1978	8	18	8	10	0	*	16	5	4	3	0	0
1979–1983	10	11	3	4	6	*	9	12	9	5	2	35
1984–1988	5	7	14	3	4	*	22	12	8	7	4	0
1989–1993	12	16	13	7	0	*	19	11	7	9	2	0
1994–1998	16	11	9	8	2	52	23	10	19	9	5	0
1999–2003	26	22	9	9	6	16	21	13	15	7	5	0
Iceland
1964–1968	0	0	0	*	*	*	11	11	11	10	*	*
1969–1973	0	0	0	*	*	*	11	11	11	10	*	*
1974–1978	10	10	10	0	*	*	0	0	0	41	0	*
1979–1983	10	10	10	0	*	*	0	0	0	41	0	*
1984–1988	0	0	0	*	26	*	35	35	35	30	17	*
1989–1993	0	0	0	*	26	*	35	35	35	30	17	*
1994–1998	23	23	23	9	12	*	30	30	30	37	8	*
1999–2003	23	23	23	9	12	*	30	30	30	37	8	*
Norway
1964–1968	11	3	8	0	0	*	0	4	5	6	0	*
1969–1973	11	3	8	0	0	*	18	8	9	2	7	*
1974–1978	20	6	11	7	9	*	8	3	10	9	3	*
1979–1983	0	23	7	6	0	*	28	7	16	9	7	39
1984–1988	17	15	24	9	5	*	67	19	26	9	2	0
1989–1993	21	22	7	12	5	*	29	9	13	2	6	0
1994–1998	23	18	14	6	3	*	25	22	10	10	6	0
1999–2003	22	18	15	13	3	*	26	15	11	10	3	0
Sweden
1964–1968	15	7	4	4	0	0	7	7	3	3	1	0
1969–1973	12	13	5	3	2	0	6	8	3	5	1	0
1974–1978	11	12	9	4	5	0	8	7	4	4	1	0
1979–1983	8	6	6	6	3	0	10	8	7	4	4	0
1984–1988	25	13	6	7	3	0	5	7	6	5	2	6
1989–1993	12	15	12	9	3	0	7	11	10	8	5	0
1994–1998	14	19	16	7	7	0	12	13	8	8	4	0
1999–2003	22	18	16	8	6	2	16	13	10	9	4	0

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

*Too few patients to calculate survival, see ref. [18].

Figure 15. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5-year relative survival for cancer of pancreas by sex and country. Nordic cancer survival study 1964–2003.

Figure 16. Trends in age-standardised (ICSS) excess death rates per 100 person years for cancer of pancreas by sex, country, and time since diagnosis. Nordic cancer survival study 1964–2003.

Table XV. Trends in survival for cancer of pancreas by sex and country. Number of tumours (N) included and the 5-year age-standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
Men
1964–1968	1 288	2 (1–3)	905	0 (0–1)	37	0 (·-·)	986	2 (1–3)	2 553	3(2–4)
1969–1973	1 689	2 (1–3)	1 033	1 (1–2)	42	0 (·-·)	1 181	1 (1–3)	2 966	4 (3–4)
1974–1978	1 796	1 (1–2)	1 191	2 (1–3)	59	2 (0–13)	1 249	2 (1–3)	2 552	3(2–4)
1979–1983	1 718	3 (2–4)	1 279	2 (1–4)	58	0 (·-·)	1 377	1 (1–2)	2 570	3(2–4)
1984–1988	1 694	2 (2–3)	1 467	3 (2–4)	74	1 (0–10)	1 434	2 (1–3)	2 628	3(3–4)
1989–1993	1 466	2 (2–3)	1 456	3 (2–4)	67	4 (1–16)	1 317	2 (2–4)	2 341	2 (2–4)
1994–1998	1 493	3 (2–4)	1 622	3 (2–4)	68	0 (·-·)	1 324	2(1–4)	2 155	4 (3–5)
1999–2003	1 728	3 (2–3)	1 758	3 (2–4)	73	3 (1–9)	1 408	3 (3–5)	2 007	4 (4–5)
Women
1964–1968	953	2 (1–3)	777	1 (1–2)	44	3 (0–21)	658	2 (1–3)	2 071	3(2–4)
1969–1973	1 400	2 (1–3)	1 003	2 (1–4)	35	0 (·-·)	859	2(1–4)	2 374	3 (3–5)
1974–1978	1 525	1 (1–2)	1 153	2 (1–3)	42	2 (0–14)	968	2(1–4)	2 257	3(2–4)
1979–1983	1 798	1 (1–2)	1 446	2 (1–4)	58	7 (3–21)	1 167	3 (2–4)	2 397	3(2–4)
1984–1988	1 686	2 (1–3)	1 695	4 (3–6)	56	0 (·-·)	1 402	2 (2–4)	2 665	4 (3–5)
1989–1993	1 669	2 (1–3)	1 913	3 (2–4)	63	4 (1–17)	1 307	3 (2–5)	2 697	4 (3–5)
1994–1998	1 652	3 (2–4)	1 913	3 (2–5)	79	3 (1–13)	1 500	4 (3–6)	2 427	5 (4–6)
1999–2003	1 902	3 (3–4)	2 135	4 (3–5)	63	1 (0–5)	1 576	4 (3–5)	2 143	5 (4–6)

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

*Too few patients to calculate survival, see ref. [18]. 0 (·-·) No patients survived five years.

Table XVI. Trends in 5-year age-specific relative survival in percent after cancer of pancreas by sex and country. Nordic cancer survival study 1964–2003.

	Men						Women
Age	0–49	50–59	60–69	70–79	80–89	90+	0–49	50–59	60–69	70–79	80–89	90+
Denmark
1964–1968	4	0	2	2	2	0	0	3	1	2	2	0
1969–1973	1	2	1	2	2	0	1	2	1	3	1	0
1974–1978	0	4	1	1	1	0	2	2	1	1	1	0
1979–1983	5	1	2	2	4	0	4	2	0	1	0	18
1984–1988	5	3	2	1	3	0	5	3	3	1	0	0
1989–1993	7	2	3	1	1	0	6	2	1	2	0	0
1994–1998	6	3	3	2	3	23	11	3	1	2	2	0
1999–2003	5	3	3	2	1	12	11	5	2	2	1	0
Finland
1964–1968	0	2	0	0	0	*	0	3	0	2	0	0
1969–1973	1	2	1	1	0	*	4	3	1	2	2	0
1974–1978	3	3	1	0	2	0	8	2	1	2	0	0
1979–1983	4	3	2	1	3	0	8	1	1	1	1	0
1984–1988	6	3	3	1	3	0	19	2	3	2	2	0
1989–1993	8	4	2	1	1	0	12	4	2	1	1	0
1994–1998	6	2	3	3	0	0	9	5	3	2	0	0
1999–2003	6	3	3	2	1	0	11	6	3	2	1	0
Iceland
1964–1968	0	0	0	0	0	*	0	0	0	11	0	*
1969–1973	0	0	0	0	0	*	0	0	0	0	0	*
1974–1978	0	0	0	7	0	*	0	0	0	7	0	*
1979–1983	0	0	0	0	0	*	13	13	13	0	0	*
1984–1988	0	0	5	0	0	*	0	0	0	0	0	*
1989–1993	9	9	5	0	0	*	8	8	8	0	0	*
1994–1998	0	0	0	0	0	*	3	3	3	5	0	*
1999–2003	7	7	3	0	0	*	1	1	1	2	0	*
Norway
1964–1968	4	2	1	2	0	*	0	2	3	2	0	*
1969–1973	3	1	2	1	0	0	8	3	1	1	0	0
1974–1978	7	1	1	2	0	0	12	0	1	1	1	0
1979–1983	2	3	2	1	0	60	6	4	2	1	2	0
1984–1988	5	3	3	1	0	0	0	7	3	1	1	0
1989–1993	9	2	2	1	1	0	11	6	3	1	0	0
1994–1998	8	3	2	1	1	0	19	2	4	2	1	16
1999–2003	9	6	3	1	1	0	11	4	4	2	2	4
Sweden
1964–1968	6	2	2	3	3	0	5	4	3	3	1	0
1969–1973	7	4	3	2	3	0	7	4	4	3	1	0
1974–1978	8	4	1	1	1	0	10	4	2	1	1	0
1979–1983	9	4	2	1	2	21	7	3	4	1	0	0
1984–1988	13	5	2	1	1	0	12	5	1	3	1	0
1989–1993	9	2	2	1	1	0	16	6	3	1	0	7
1994–1998	11	5	4	2	1	0	19	6	4	1	1	0
1999–2003	15	6	4	2	1	0	17	5	5	2	1	0

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

*Too few patients to calculate survival, see ref. [18].

Engholm G, Gislum M, Bray F, Hakulinen T. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964–2003 followed up to the end of 2006. Material and methods. Acta Oncol 2010.

 Google Scholar